Replies to post #17794 on Seelos Therapeutics Inc (SEEL)

[Dimitrios George]

I have followed both Gale and NWBO and agree with your points. (I follow NWBO because they may have a better mousetrap for cancer vaccines.)

The videos that were previously done were not bad but not great. Damaj, who was the interviewee for most of them, is not the easiest guy to understand because of his accent. Damaj does have strong scientist cred. Pascoe, while not a scientist, is telegenic as timothy mentioned and does present well.

I also agree that it is probably about time to hear more from Apricus. I suspect they will hold up until the quarterly conference call in mid-August to have a better assessment from Takeda on how the roll out is going. For sure at the conf call Pascoe will have to say something about Femprox and Actavis.